Short answer
Esperion Therapeutics, Inc. (ESPR) filed an 8-K current report with the SEC on July 8, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved Parent’s acquisition merger, clearing the key shareholder-vote condition.
Esperion Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders approved Parent’s acquisition merger, clearing the key shareholder-vote condition
- Approval vote: 135,326,793 for, 22,750,628 against, 496,194 abstentions
- Quorum represented 158,573,615 shares, or 61.53% of outstanding stock
- Advisory executive merger-compensation vote approved: 129,937,383 for versus 22,283,787 against
- Closing remains subject to merger-agreement conditions; CVR payments depend on future net-sales milestones
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Esperion Therapeutics, Inc. 8-K filings
Get the next ESPR 8-K as it lands
Follow ESPR for push alerts, or ask the research agent what this filing means.